Patent · US Active

Antibodies that specifically bind alpha klotho

US11143661B2 · kind B2 · utility

0Cited by
0References
14Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 22, 2020
Grant dateOct 12, 2021
Priority date
Expiry dateMay 22, 2040

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/56
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

An antibody and/or binding fragment thereof, wherein the antibody and/or binding fragment thereof comprises a light chain variable region and a heavy chain variable region, the light chain variable region comprising complementarity determining region (CDR) CDR-L3 and the heavy chain variable region comprising CDR-H1, CDR-H2 and CDR-H3, with the amino acid sequences of said CDRs comprising one or more of the sequences set forth below: CDR-L3; selected from any one of SEQ ID NOs: 123, 126-130, 142, 148 or 149; CDR-H1: SEQ ID NOs: 121 or 124; CDR-H2; SEQ ID NOs: 122 or 125; and/or CDR-H3: selected from any one of SEQ ID NOs: 196-226.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.